|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-0.21/-0.44
|
企业价值
91.26M
|
资产负债 |
每股账面净值
1.05
|
现金流量 |
现金流量率
--
|
损益表 |
收益
19.61M
|
每股收益
0.89
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|

同行比较之报价最少15分钟延迟
业务概览
|
|||
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment includes image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging andComputed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other. |